Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-26-023862
Filing Date
2026-05-15
Accepted
2026-05-15 16:31:51
Documents
80
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1096365
2 EX-31.1 ex31-1.htm EX-31.1 35567
3 EX-31.2 ex31-2.htm EX-31.2 18662
4 EX-32.1 ex32-1.htm EX-32.1 15393
5 EX-32.2 ex32-2.htm EX-32.2 8003
6 GRAPHIC form10-q_001.jpg GRAPHIC 7558
7 GRAPHIC form10-q_002.jpg GRAPHIC 52808
  Complete submission text file 0001493152-26-023862.txt   6738393

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE scnx-20260331.xsd EX-101.SCH 58531
9 XBRL CALCULATION FILE scnx-20260331_cal.xml EX-101.CAL 63750
10 XBRL DEFINITION FILE scnx-20260331_def.xml EX-101.DEF 309773
11 XBRL LABEL FILE scnx-20260331_lab.xml EX-101.LAB 483219
12 XBRL PRESENTATION FILE scnx-20260331_pre.xml EX-101.PRE 413032
83 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 701975
Mailing Address 20 AUSTIN BLVD. COMMACK NY 11725
Business Address 20 AUSTIN BLVD. COMMACK NY 11725 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39199 | Film No.: 26988583
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)